From: Neural stem cells: ready for therapeutic applications?
NCT number | Title | Recruitment | Conditions | Interventions | Sponsor/Collaborators | Phases | Enrollment | Start date | Completion date |
---|---|---|---|---|---|---|---|---|---|
NCT01344993 | Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration | Recruiting | Dry Age Related Macular Degeneration | Biological: MA09-hRPE implantation | Advanced Cell Technology | Phase 1-2 | 16 | April 2011 | December 2014 |
NCT01345006 | Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Stargardt’s Macular Dystrophy | Recruiting | Stargardt’s Macular Dystrophy | Biological: MA09-hRPE implantation | Advanced Cell Technology | Phase 1-2 | 16 | April 2011 | December 2014 |
NCT01469832 | Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt’s Macular Dystrophy (SMD) | Recruiting | Stargardt’s Macular Dystrophy|Fundus Flavimaculatus|Juvenile Macular Dystrophy | Biological: MA09-hRPE implantation | Advanced Cell Technology | Phase 1-2 | 16 | November 2011 | December 2014 |
NCT01625559 | Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt’s Macular Dystrophy (SMD) | Recruiting | Stargardt’s Macular Dystrophy | Biological: MA09-hRPE implantation | CHA Bio & Diostech | Phase 1 | 3 | September 2012 | October 2014 |
NCT01632527 | Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) | Recruiting | Age Related Macular Degeneration|Macular Degeneration|AMD | Drug: HuCNS-SC cells implantation | StemCells, Inc. | Phase 1-2 | 16 | June 2012 | June 2014 |
NCT01674829 | A Phase I/IIa, Open-Label, Single-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Advanced Dry Age-related Macular Degeneration (AMD) | Recruiting | Dry Age Related Macular Degeneration | Biological: MA09-hRPE implantation | CHA Bio & Diostech | Phase 1-2 | 12 | September 2012 | April 2016 |
NCT01691261 | A Study Of Implantation Of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium In Subjects With Acute Wet Age Related Macular Degeneration And Recent Rapid Vision Decline | Not yet recruiting | Age Related Macular Degeneration | Biological: PF-05206388 implantation | Pfizer|University College, London | Phase 1 | 10 | April 2014 | July 2016 |
NCT02122159 | Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration | Not yet recruiting | Myopic Macular Degeneration | Biological: MA09-hRPE implantation | University of California, Los Angeles|Advanced Cell Technology, Inc. | Phase 1-2 | Not specified | Not specified | Not specified |